Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization
- 1 June 2005
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 62 (2) , 392-396
- https://doi.org/10.1016/j.ijrobp.2004.10.003
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IVInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Dose response in prostate cancer with 8–12 years’ follow-upInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2002
- High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patientsInternational Journal of Radiation Oncology*Biology*Physics, 2002
- A practical method to achieve prostate gland immobilization and target verification for daily treatmentInternational Journal of Radiation Oncology*Biology*Physics, 2001
- HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose–volume analysisInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2000
- 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional reviewInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Zonal Distribution of Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1988